Information Library
Pediatrics
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Challenging Expectations
June 24, 2010
Quintiles' global coverage, experience and the systems to do the job were key to the success of this challenging trial. Through careful selection of countries -
Clinical – smarter trials, accelerated outcomes
April 2, 2010
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
FDA Requirements for Clinical Studies in Pediatric Patients
April 1, 2010
FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy -
Propelling Pediatric Research
April 1, 2010
Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study -
Boosting Pediatric Enrollment
April 1, 2010
Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks. -
Commercial – identify, promote and prove treatment value
April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
Data-Driven Patient Recruitment
March 23, 2010
Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials. -
Regulations for Clinical Studies in Pediatric Patients in the European Union
March 10, 2010
After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric -
Sub-Saharan Africa Phase II/III Fact Sheet
July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. -
Pediatric Expertise Conquers Enrollment Challenges
March 27, 2009
Quintiles’ pediatric specialists are thoroughly familiar with the current regulatory climate and pathways to pursue Pediatric Exclusivity. So when a major pharmaceutical company came to us for help gaining an exclusivity ruling, we understood immediately that the deadlines we were facing were unchangeable.